Weekly Top News – Psoriasis – May 25, 2020

May 25, 2020

Enbrel (etanercept) / Pfizer, Amgen
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients (clinicaltrials.gov) – May 21, 2020 – P; N=1; Not yet recruiting; Sponsor: Pfizer


Ilumya (tildrakizumab-asmn) / Sun Pharma, Almirall; Skilarence (dimethyl fumarate) / Almirall; Fumaderm (dimethyl fumarate) / Biogen
TRANSITION: Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy (clinicaltrials.gov) – May 20, 2020 – P4; N=250; Active, not recruiting; Sponsor: Almirall, S.A.; Recruiting –> Active, not recruiting

No Comments

Post a Comment